320 related articles for article (PubMed ID: 11353785)
1. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
[TBL] [Abstract][Full Text] [Related]
3. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.
Sellers TA; Mink PJ; Cerhan JR; Zheng W; Anderson KE; Kushi LH; Folsom AR
Ann Intern Med; 1997 Dec; 127(11):973-80. PubMed ID: 9412302
[TBL] [Abstract][Full Text] [Related]
4. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
6. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
Liu JY; Chen TJ; Hwang SJ
Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187426
[TBL] [Abstract][Full Text] [Related]
7. Vaginal Estrogen Therapy Use and Survival in Females With Breast Cancer.
McVicker L; Labeit AM; Coupland CAC; Hicks B; Hughes C; McMenamin Ú; McIntosh SA; Murchie P; Cardwell CR
JAMA Oncol; 2024 Jan; 10(1):103-108. PubMed ID: 37917089
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in premenopausal women: recurrence and survival rates and relationship to hormone replacement therapy.
Durna EM; Heller GZ; Leader LR; Sjoblom P; Eden JA; Wren BG
Climacteric; 2004 Sep; 7(3):284-91. PubMed ID: 15669553
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
[TBL] [Abstract][Full Text] [Related]
10. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
[TBL] [Abstract][Full Text] [Related]
11. A case-control study of hormone replacement therapy after primary surgical breast cancer treatment.
Ursic-Vrscaj M; Bebar S
Eur J Surg Oncol; 1999 Apr; 25(2):146-51. PubMed ID: 10218456
[TBL] [Abstract][Full Text] [Related]
12. Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy.
Manjer J; Malina J; Berglund G; Bondeson L; Garne JP; Janzon L
Int J Cancer; 2001 Jun; 92(6):919-22. PubMed ID: 11351317
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer and hormone-replacement therapy in the Million Women Study.
Beral V;
Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk.
Col NF; Hirota LK; Orr RK; Erban JK; Wong JB; Lau J
J Clin Oncol; 2001 Apr; 19(8):2357-63. PubMed ID: 11304788
[TBL] [Abstract][Full Text] [Related]
15. Do perceptions of risk and quality of life affect use of hormone replacement therapy by postmenopausal women?
Scheid DC; Coleman MT; Hamm RM
J Am Board Fam Pract; 2003; 16(4):270-7. PubMed ID: 12949027
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality.
Durna EM; Wren BG; Heller GZ; Leader LR; Sjoblom P; Eden JA
Med J Aust; 2002 Oct; 177(7):347-51. PubMed ID: 12358575
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study.
Kotsopoulos J; Huzarski T; Gronwald J; Moller P; Lynch HT; Neuhausen SL; Senter L; Demsky R; Foulkes WD; Eng C; Karlan B; Tung N; Singer CF; Sun P; Lubinski J; Narod SA
Breast Cancer Res Treat; 2016 Jan; 155(2):365-73. PubMed ID: 26780555
[TBL] [Abstract][Full Text] [Related]
18. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study.
Feigelson HS; Jonas CR; Teras LR; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):220-4. PubMed ID: 14973094
[TBL] [Abstract][Full Text] [Related]
19. The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival.
Sener SF; Winchester DJ; Winchester DP; Du H; Barrera E; Bilimoria M; Krantz S; Rabbitt S
Am J Surg; 2009 Mar; 197(3):403-7. PubMed ID: 19245923
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
Fournier A; Berrino F; Riboli E; Avenel V; Clavel-Chapelon F
Int J Cancer; 2005 Apr; 114(3):448-54. PubMed ID: 15551359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
